Home Message from CEO About US Business Operations Features of Our Technology Contact
Site Map Japanese  

 While ImmunoFrontier, Inc has several core technologies, “CHP technology” is expected to be put into practical use ealiest of all. Wide range of application is now in progress to CHP cancer protein vaccines and next generation CHP bio-medicines. We are also trying to establish various new technologies for promoting the creation of next generation cancer DNA vaccines and therapeutics for immune diseases.

・ CHP Technology and Its Application to Cancer Protein Vaccines (Click here for more information) 
Click here for more information
 
・ Cancer DNA Vaccines (Click here for more information) 
Click here for more information
 
・ References